Ruiz-Treviño JJ, Márquez-Espriella C, Vallarta RRA, Gutiérrez SJE

Language: Spanish
References: 20
Page: 88-96
PDF size: 484.83 Kb.

ABSTRACT

Advanced dermatopathy of chronic venous hypertension includes cutaneous hyperpigmentation, dermic atrophy, and subcutaneous sclerosis, making patients with long-standing venous hypertension prone to wounds. Due to the specific characteristics of these non-healing wounds, many of these patients are referred to the plastic surgeon after multiple treatments having sub-optimal results. Today, we still don’t have an effective treatment to revert the cutaneous changes of these patients. We present a complementary treatment of the integral management of patients with long-standing venous insufficiency aimed at improving their advanced dermatopathy with the ultimate goal of reducing some of the loco-regional and systemic complications that impact the quality of life of these patients. From April 2011 to April 2014 we treated 70 patients with venous dermatopathy by lipocellular regeneration. 20 patients had bilateral disease (28.5%). This was an ambulatory procedure with local anesthesia in every case. Ultrasonographic comparative measurements of cutaneous thickness and clinical photography of the affected legs were used. There were no complications associated with the procedure. 64 patients showed clinical improvement (91.4%). In conclusion, lipocellular regeneration is a reproducible, ambulatory, low cost, low morbidity procedure that can be a useful adjunct procedure for the integral treatment of patients with long-standing venous insufficiency.

REFERENCES

1. Callam MJ. Epidemiology of varicose veins. Br J Surg. 1994; (81): 167-173.

2. Marinel J, Calvo J, Vila R, Lapiedra O. Epidemiología de redes venosas. Fisiopatología de la insuficiencia venosa crónica. An Cir Card Vasc. 2004; 10 (2): 96-143.

3. Sigler ML, Castañeda GR, Rish FL. Insuficiencia venosa crónica en la República Mexicana. Rev Mex Angiol. 2004; 32 (2): 44-46.

4. Cueto-Manzano AM, Rojas-Campos E. Status of renal replacement therapy and peritoneal dialysis in Mexico. Perit Dial Int. 2007; 27: 142-148.

5. Hands L, Murphy M, Sharp M, Ray-Chaudhuri S. Vascular surgery. Ed. London: Oxford University Press, 2007.

6. Caggiati A. Nomenclature of the veins of the lower limbs: An international interdisciplinary consensus statement. J Vasc Surg. 2002; 36 (2): 416-422.

7. Gernot Rassner. Manual y Atlas de Dermatología. 5ª ed. Ediciones Harcourt. Madrid, España: 1999. pp. 306-309.

8. Barron GS, Jacob SE, Kirsner RS. Dermatologic complications of chronic venous disease: medical management and beyond. Ann Vasc Surg. 2007; 21 (5): 652-662.

9. De-Godoy PJM. Treatment of stasis dermatitis using aminaphtone: a case series. J Med Case Reports. 2010; (4): 295.

10. Halberg N, Wernstedt-Asterholm I, Scherer PE. The Adipocyte as an endocrine cell. Endocrinol Metab Clin North Am. 2008; (37): 753-768.

11. Tobita M, Orbay H, Mizuno H. Adipose-derived stem cells: current findings and future perspectives. Discov Med. 2011; 11 (57): 160-170.

12. Tran TT, Kahn CR. Transplantation of adipose tissue and stem cells: role in metabolism and disease. Nat Rev Endocrinol. 2010; 6 (4): 195-213.

13. Musina RA, Bekchanova ES, Sukhikh GT. Comparison of mesenchymal stem cells obtained from different human tissues. Bull Exp Biol Med. 2005; 139 (4): 504-509.

14. Ogawa R. The importance of adipose-derived stem cells and vascularized tissue regeneration in the field of tissue transplantation. Curr Stem Cell Res Ther. 2006; (1): 13-20.

15. Amos PJ, Shang H, Bailey AM, Taylor A, Katz AJ, Peirce SM. IFATS collection: The role of human adipose-derived stromal cells in inflammatory microvascular remodeling and evidence of a perivascular phenotype. Stem Cells. 2008; 26 (10): 2682-2690.

16. Brayfield C, Marra K, Rubin JP. Adipose stem cells for soft tissue regeneration. Handchir Mikrochir Plast Chir. 2010; 42 (2): 124-128.

17. Kim WS, Park BS, Sung JH. The wound-healing and antioxidant effects of adipose-derived stem cells. Expert Opin Biol Ther. 2009; 9 (7): 879-887.

18. Schäffler A, Büchler C. Concise review: adipose tissue-derived stromal cells–basic and clinical implications for novel cell-based therapies. Stem Cells. 2007; 25 (4): 818-827.

19. Ebrahimian TG, Pouzoulet F, Squiban C, Buard V, André M et al. Cell therapy based on adipose tissue-derived stromal cells promotes physiological and pathological wound healing. Arterioscler Thromb Vasc Biol. 2009; 29 (4): 503-510.

20. Hanson SE, Bentz ML, Hematti P. Mesenchymal stem cell therapy for nonhealing cutaneous wounds. Plast Reconstr Surg. 2010; 125 (2): 510-516.